Macular Degeneration Treatment and Research
Marco A. Zarbin, MD, PhD, Chair of Services and Director
(973) 972-2065
The Center for Macular Degeneration Treatment and Research provides state-of-the-art treatment for Age-Related Macular Degeneration (AMD), including the latest FDA approved treatment modalities for neovascular AMD – Macugen (pegaptanib sodium injection) and photodynamic (Visudyne) therapy. Experimental drugs and operations (in the context of Institutional Review Board-approved clinical trials) are also available. The Center is involved in a number of research projects and clinical trials including those related to various aspects of photoreceptor and retinal pigment epithelium transplantation.
Staff
Monique S. Roy, MD
Neelakshi Bhagat, MD
Other Recent News Stories